Literature DB >> 30520100

Has_circ_0055625 from circRNA profile increases colon cancer cell growth by sponging miR-106b-5p.

Jian Zhang1, Hua Liu1, Ping Zhao1, Hao Zhou1, Tao Mao1.   

Abstract

Circular RNAs (circRNA) are endogenous noncoding RNAs and play important roles in cancer; however, the roles of circRNAs in colon cancer are far from clear. The circRNA expression profile in colon cancer tissues was analyzed by microarray. The data from microarray showed that there were 198 upregulated and 136 downregulated circRNAs in colon cancer tissues. Among the top 10 upregulated circRNAs, hsa_circ_0055625 (circ_0055625) was confirmed to be significantly upregulated in colon cancer tissues. Further analysis demonstrated that circ_0055625 might get involved in the pathogenesis of colon cancer by functioning as miRNA sponges and performed bioinformatics analysis of the predicted circ_0055625/miR-106b-5p (miR-106b)/ITGB8 network. Moreover, we found that circ_0055625 expression was associated with pathological TNM stage and metastasis. These data indicated that circ_0055625/miR-106b/ITGB8 played a role in promoting tumor growth and metastasis, which suggested that circ_0055625 was a potential biomarker of colon cancer.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  ITGB8; circRNA; colon cancer; hsa_circ_0055625; miR-106b

Mesh:

Substances:

Year:  2018        PMID: 30520100     DOI: 10.1002/jcb.27355

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  20 in total

1.  Circ-0001313/miRNA-510-5p/AKT2 axis promotes the development and progression of colon cancer.

Authors:  Fang-Ling Tu; Xi-Qing Guo; Hai-Xia Wu; Zhi-Yun He; Fang Wang; Ai-Jun Sun; Xu-Dong Dai
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

2.  MicroRNA-106b-5p (miR-106b-5p) suppresses the proliferation and metastasis of cervical cancer cells via down-regulating fibroblast growth factor 4 (FGF4) expression.

Authors:  Lei Hongwei; Li Juan; Xu Xiaoying; Fan Zhijun
Journal:  Cytotechnology       Date:  2022-06-06       Impact factor: 2.040

3.  Potential Role of circPVT1 as a proliferative factor and treatment target in esophageal carcinoma.

Authors:  Rongrong Zhong; Zhuozhi Chen; Ting Mo; Zimo Li; Peng Zhang
Journal:  Cancer Cell Int       Date:  2019-10-15       Impact factor: 5.722

Review 4.  The crosstalk between circular RNAs and the tumor microenvironment in cancer metastasis.

Authors:  Ying Shao; Bingjian Lu
Journal:  Cancer Cell Int       Date:  2020-09-11       Impact factor: 5.722

5.  Hsa_circ_0020095 Promotes Oncogenesis and Cisplatin Resistance in Colon Cancer by Sponging miR-487a-3p and Modulating SOX9.

Authors:  Yanlai Sun; Zhen Cao; Junqi Shan; Yang Gao; Xin Liu; Dejian Ma; Zengjun Li
Journal:  Front Cell Dev Biol       Date:  2021-01-15

6.  Hsa_Circ_0007843 Acts as a mIR-518c-5p Sponge to Regulate the Migration and Invasion of Colon Cancer SW480 Cells.

Authors:  Jin Hua He; Ze Ping Han; Jin Gen Luo; Jian Wei Jiang; Jia Bin Zhou; Wei Ming Chen; Yu Bing Lv; Meng Ling He; Lei Zheng; Yu Guang Li; Ji Dong Zuo
Journal:  Front Genet       Date:  2020-02-25       Impact factor: 4.599

Review 7.  Circular RNA is a popular molecule in tumors of the digestive system (Review).

Authors:  Hao-Ying Wang; Yu-Ping Wang; Xi Zeng; Ya Zheng; Qing-Hong Guo; Rui Ji; Yong-Ning Zhou
Journal:  Int J Oncol       Date:  2020-04-27       Impact factor: 5.650

Review 8.  Novel potential tumor biomarkers: Circular RNAs and exosomal circular RNAs in gastrointestinal malignancies.

Authors:  Yezhao Wang; Zhe Li; Suyuan Xu; Junming Guo
Journal:  J Clin Lab Anal       Date:  2020-05-17       Impact factor: 2.352

Review 9.  Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review).

Authors:  Xiaorui Zhao; Yue Wang; Qiongfang Yu; Pei Yu; Qiaoyu Zheng; Xue Yang; Dian Gao
Journal:  Int J Mol Med       Date:  2020-09-16       Impact factor: 4.101

10.  Sevoflurane Suppresses Colon Cancer Cell Malignancy by Regulating circ-PI4KA.

Authors:  Suqing Sun; Peng Wang; Lijie Ren; Hongli Wang; Yanli Zhan; Shimin Shan
Journal:  Onco Targets Ther       Date:  2021-05-20       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.